Is the One-Compartment Model with First Order Absorption a Useful Approximation?
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2147, doi. 10.1007/s11095-023-03582-1
- By:
- Publication type:
- Article
Works matching IS 07248741 AND DT 2023 AND VI 40 AND IP 9
Results: 14
1
2
Hollow Mesoporous Silica Nanoparticles for Dual Chemo-starvation Therapy of Hepatocellular Carcinoma.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2215, doi. 10.1007/s11095-023-03599-6
- By:
- Publication type:
- Article
3
TIMP-1 Protects Tight Junctions of Brain Endothelial Cells From MMP-Mediated Degradation.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2121, doi. 10.1007/s11095-023-03593-y
- By:
- Publication type:
- Article
4
Thermal degradation of Affinisol HPMC: Optimum Processing Temperatures for Hot Melt Extrusion and 3D Printing.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2253, doi. 10.1007/s11095-023-03592-z
- By:
- Publication type:
- Article
5
Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2239, doi. 10.1007/s11095-023-03586-x
- By:
- Publication type:
- Article
6
Physiologically Based Pharmacokinetic Modeling for Prediction of 5-FU Pharmacokinetics in Cancer Patients with Hepatic Impairment After 5-FU and Capecitabine Administration.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2177, doi. 10.1007/s11095-023-03585-y
- By:
- Publication type:
- Article
7
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2133, doi. 10.1007/s11095-023-03596-9
- By:
- Publication type:
- Article
8
Effect of P-glycoprotein and Cotreatment with Sofosbuvir on the Intestinal Permeation of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Fumarate.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2109, doi. 10.1007/s11095-023-03581-2
- By:
- Publication type:
- Article
9
Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2155, doi. 10.1007/s11095-023-03580-3
- By:
- Publication type:
- Article
10
Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2167, doi. 10.1007/s11095-023-03578-x
- By:
- Publication type:
- Article
11
Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
12
Drug-Polymer Miscibility and the Overlap Concentration (C*) as Measured by Rheology: Variation of Polymer Structure.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2229, doi. 10.1007/s11095-023-03570-5
- By:
- Publication type:
- Article
13
SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System Parameters.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2195, doi. 10.1007/s11095-023-03567-0
- By:
- Publication type:
- Article
14
Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 9, p. 2103, doi. 10.1007/s11095-023-03548-3
- By:
- Publication type:
- Article